Search Results - "GRÜNDER, G"

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017 by Hiemke, C, Bergemann, N, Clement, H W, Conca, A, Deckert, J, Domschke, K, Eckermann, G, Egberts, K, Gerlach, M, Greiner, C, Gründer, G, Haen, E, Havemann-Reinecke, U, Hefner, G, Helmer, R, Janssen, G, Jaquenoud, E, Laux, G, Messer, T, Mössner, R, Müller, M J, Paulzen, M, Pfuhlmann, B, Riederer, P, Saria, A, Schoppek, B, Schoretsanitis, G, Schwarz, M, Gracia, M Silva, Stegmann, B, Steimer, W, Stingl, J C, Uhr, M, Ulrich, S, Unterecker, S, Waschgler, R, Zernig, G, Zurek, G, Baumann, P

“…Therapeutic drug monitoring (TDM) is the quantification and interpretation of drug concentrations in blood to optimize pharmacotherapy. It considers the…”
Get more information

Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants by Eap, C. B., Gründer, G., Baumann, P., Ansermot, N., Conca, A., Corruble, E., Crettol, S., Dahl, M. L., de Leon, J., Greiner, C., Howes, O., Kim, E., Lanzenberger, R., Meyer, J. H., Moessner, R., Mulder, H., Müller, D. J., Reis, M., Riederer, P., Ruhe, H. G., Spigset, O., Spina, E., Stegman, B., Steimer, W., Stingl, J., Suzen, S., Uchida, H., Unterecker, S., Vandenberghe, F., Hiemke, C.

“…Objectives: More than 40 drugs are available to treat affective disorders. Individual selection of the optimal drug and dose is required to attain the highest…”
Get full text

Oxytocin plasma concentrations after single intranasal oxytocin administration – A study in healthy men by Gossen, A, Hahn, A, Westphal, L, Prinz, S, Schultz, R.T, Gründer, G, Spreckelmeyer, K.N

“…Abstract The neuropeptide oxytocin has become a subject of great interest in studies investigating human social cognition. Single intranasal administration of…”
Get full text

Venlafaxine’s therapeutic reference range in the treatment of depression revised: a systematic review and meta-analysis by Lense, X.M., Hiemke, C., Funk, C.S.M., Havemann-Reinecke, U., Hefner, G., Menke, A., Mössner, R., Riemer, T.G., Scherf-Clavel, M., Schoretsanitis, G., Gründer, G., Hart, X.M.

“…Introduction The selective serotonin and norepinephrine reuptake inhibitor venlafaxine is among the most prescribed antidepressant drugs worldwide and,…”
Get full text

Concentrations of escitalopram in blood of patients treated in a naturalistic setting: focus on patients with alcohol and benzodiazepine use disorder by Hart, X. M., Heesen, S., Schmitz, C. N., Dörfler, S., Wedekind, D., Gründer, G., Hiemke, C., Havemann-Reinecke, U.

“…The selective serotonin reuptake inhibitor escitalopram (ESC) is indicated for the treatment of major depressive disorder (MDD) and of generalized anxiety…”
Get full text

C.05.02 Recent advances in nuclear medicine: how this is helping to better understand and guide long-term antipsychotic use by Gründer, G

Get full text

Neural correlates of naturalistic social cognition: brain-behavior relationships in healthy adults by Deuse, L, Rademacher, L M, Winkler, L, Schultz, R T, Gründer, G, Lammertz, S E

“…Being able to infer the thoughts, feelings and intentions of those around us is indispensable in order to function in a social world. Despite growing interest…”
Get full text

Pharmacokinetic differences for risperidone between genders by Schoretsanitis, G, Haen, E, Hiemke, C, Gründer, G, Paulzen, M

Get full text

Correction to: Assessment of Psychosocial Functioning in a Large Cohort of Patients with Schizophrenia by Kossmann, C., Heller, J., Brüne, M., Schulz, C., Heinze, M., Cordes, J., Mühlbauer, B., Rüther, E., Timm, J., Gründer, G., Juckel, G.

Get full text

Association of Common Polymorphisms in the Nicotinic Acetylcholine Receptor Alpha4 Subunit Gene with an Electrophysiological Endophenotype in a Large Population-Based Sample by Mobascher, A, Diaz-Lacava, A, Wagner, M, Gallinat, J, Wienker, T F, Drichel, D, Becker, T, Steffens, M, Dahmen, N, Gründer, G, Thürauf, N, Kiefer, F, Kornhuber, J, Toliat, M R, Thiele, H, Nürnberg, P, Steinlein, O, Winterer, G

“…Variation in genes coding for nicotinic acetylcholine receptor (nAChR) subunits affect cognitive processes and may contribute to the genetic architecture of…”
Get full text

Assessment of Psychosocial Functioning in a Large Cohort of Patients with Schizophrenia by Kossmann, C., Heller, J., Brüne, M., Schulz, C., Heinze, M., Cordes, J., Mühlbauer, B., Rüther, E., Timm, J., Gründer, G., Juckel, G.

“…Background This study addresses the question of whether psychosocial functioning measured by the Personal and Social Performance (PSP) Scale is related to…”
Get full text

Replik by Gründer, G

Get full text

Anxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: a [ C]DASB PET study by Reimold, M, Batra, A, Knobel, A, Smolka, M N, Zimmer, A, Mann, K, Solbach, C, Reischl, G, Schwärzler, F, Gründer, G, Machulla, H-J, Bares, R, Heinz, A

“…Serotonergic dysfunction may contribute to negative mood states in affective disorders. Some in vivo imaging studies showed reduced availability of serotonin…”
Get full text

Therapeutic plasma concentrations of antidepressants and antipsychotics: lessons from PET imaging by Gründer, G, Hiemke, C, Paulzen, M, Veselinovic, T, Vernaleken, I

“…Therapeutic Drug Monitoring (TDM) of psychotropic drugs is strongly depending on the validity of recommended therapeutic plasma concentration reference ranges…”
Get more information

S.01.03 Dopamine partial agonists – do they live up to their expectations? by Gründer, G

Get full text

An Evaluation of the Comparative Effectiveness of Clomethiazole Against Diazepam in the Treatment of Alcohol Withdrawal Syndrome in Routine Clinical Practice by Kamudoni, P, Gründer, G, Sychla, H, Juha, B

Get full text

Antidepressive agents and suicidal tendencies by Gründer, G, Veselinović, T, Paulzen, M

“…In the last 2 years the discussions on the question whether antidepressants, especially selective serotonin reuptake inhibitors (SSRIs) can lead to…”
Get full text

Aripiprazole: pharmacodynamics of a dopamine partial agonist for the treatment of schizophrenia by Gründer, G, Kungel, M, Ebrecht, M, Göröcs, T, Modell, S

“…Aripiprazole is the first approved atypical antipsychotic with a mechanism of action that exerts a partial agonism with high affinity at Dopamin D2- and…”
Get more information

Dopamine-modulated aversive emotion processing fails in alcohol-dependent patients by Kienast, T, Schlagenhauf, F, Rapp, M A, Wrase, J, Daig, I, Buchholz, H-G, Smolka, M N, Gründer, G, Kumakura, Y, Cumming, P, Charlet, K, Bartenstein, P, Hariri, A R, Heinz, A

“…Negative mood states after alcohol detoxification may enhance the relapse risk. As recently shown in healthy volunteers, dopamine storage capacity (V d) in the…”
Get more information

The P300 event-related potential and smoking — A population-based case–control study by Mobascher, A., Brinkmeyer, J., Warbrick, T., Wels, C., Wagner, M., Gründer, G., Spreckelmeyer, K.N., Wienker, T., Diaz Lacava, A., Dahmen, N., Böttcher, M., Thuerauf, N., Clepce, M., Kiefer, F., De Millas, W., Gallinat, J., Winterer, G.

“…A better understanding of the factors underlying habitual tobacco smoking may further new strategies to go about this major health problem. The P300…”
Get full text